Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
<p>Advances in high-throughput isolation of neutralizing human monoclonal antibodies (mAbs) have enabled development of mAb-based therapeutics for many viruses (e.g., HIV-1, Ebola, SARS-CoV-2). This approach has recently been applied to isolate antimalarial human mAbs against the Plasmodium fa...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2022
|
| Subjects: |